Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP LIGNO Trial
NCT05897385Completed
- Sponsor
- Universiti Malaya
- Start
- Aug 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine in postoperative pain (2 arms), sponsored by Universiti Malaya. Primary endpoint: Postoperative pain score at 48 hours. Started Aug 2023; status: completed.
02
Drugs
lidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05897385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05897385.